HR, S., L, J., R, D., & MC, M. (2004). Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450. Psychopharmacology, 171(2), 229. https://doi.org/10.1007/s00213-003-1599-3
Chicago Style (17th ed.) CitationHR, Sumnall, Jerome L, Doblin R, and Mithoefer MC. "Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's Disorder, Psychomotor Problems and Dopaminergic Neurotoxicity in Recreational Ecstasy/MDMA Users. Psychopharmacology 167(4):449-450." Psychopharmacology 171, no. 2 (2004): 229. https://doi.org/10.1007/s00213-003-1599-3.
MLA (9th ed.) CitationHR, Sumnall, et al. "Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's Disorder, Psychomotor Problems and Dopaminergic Neurotoxicity in Recreational Ecstasy/MDMA Users. Psychopharmacology 167(4):449-450." Psychopharmacology, vol. 171, no. 2, 2004, p. 229, https://doi.org/10.1007/s00213-003-1599-3.